{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T23:00:28Z","timestamp":1784242828728,"version":"3.55.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2023,8,5]],"date-time":"2023-08-05T00:00:00Z","timestamp":1691193600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,8,5]],"date-time":"2023-08-05T00:00:00Z","timestamp":1691193600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81803119"],"award-info":[{"award-number":["81803119"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Science and Technology Program of Guangzhou","award":["2023A04J2432"],"award-info":[{"award-number":["2023A04J2432"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"DOI":"10.1007\/s10238-023-01154-6","type":"journal-article","created":{"date-parts":[[2023,9,6]],"date-time":"2023-09-06T08:02:34Z","timestamp":1693987354000},"page":"4731-4743","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["A comprehensive analysis of type 1 interferon gene signatures in systematic lupus erythematosus and prediction of the crucial susceptible factor for Sj\u00f6gren syndrome"],"prefix":"10.1007","volume":"23","author":[{"given":"Xiangbin","family":"Mi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuan","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanshan","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,5]]},"reference":[{"issue":"11","key":"1154_CR1","doi-asserted-by":"crossref","first-page":"C81","DOI":"10.7326\/AITC202006020","volume":"172","author":"M Kiriakidou","year":"2020","unstructured":"Kiriakidou M, Ching CL. systemic lupus erythematosus. Ann Intern Med. 2020;172(11):C81\u201396.","journal-title":"Ann Intern Med"},{"key":"1154_CR2","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.coi.2020.10.014","volume":"67","author":"M Postal","year":"2020","unstructured":"Postal M, Vivaldo JF, Fernandez-Ruiz R, Paredes JL, Appenzeller S, Niewold TB. Type I interferon in the pathogenesis of systemic lupus erythematosus. Curr Opin Immunol. 2020;67:87\u201394.","journal-title":"Curr Opin Immunol"},{"issue":"3 Pt B","key":"1154_CR3","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.jid.2021.11.031","volume":"142","author":"R Fernandez-Ruiz","year":"2022","unstructured":"Fernandez-Ruiz R, Niewold TB. Type I interferons in autoimmunity. J Invest Dermatol. 2022;142(3 Pt B):793\u2013803.","journal-title":"J Invest Dermatol"},{"issue":"2","key":"1154_CR4","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/s12016-020-08798-2","volume":"59","author":"J Jiang","year":"2020","unstructured":"Jiang J, Zhao M, Chang C, Wu H, Lu Q. Type I interferons in the pathogenesis and treatment of autoimmune diseases. Clin Rev Allergy Immunol. 2020;59(2):248\u201372.","journal-title":"Clin Rev Allergy Immunol"},{"issue":"5","key":"1154_CR5","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/s41564-020-0673-5","volume":"5","author":"TP Burke","year":"2020","unstructured":"Burke TP, Engstr\u00f6m P, Chavez RA, Fonbuena JA, Vance RE, Welch MD. Inflammasome-mediated antagonism of type I interferon enhances Rickettsia pathogenesis. Nat Microbiol. 2020;5(5):688\u201396.","journal-title":"Nat Microbiol"},{"issue":"6","key":"1154_CR6","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1136\/annrheumdis-2021-221835","volume":"81","author":"F Chasset","year":"2022","unstructured":"Chasset F, Mathian A, Dorgham K, Ribi C, Trendelenburg M, Huynh-Do U, Roux-Lombard P, Courvoisier DS, Amoura Z, Gorochov G, Chizzolini C. Serum interferon-\u03b1 levels and IFN type I-stimulated genes score perform equally to assess systemic lupus erythematosus disease activity. Ann Rheum Dis. 2022;81(6):901\u20133.","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"1154_CR7","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/s41581-022-00581-0","volume":"18","author":"S Steiger","year":"2022","unstructured":"Steiger S, Anders HJ. Interferon blockade in lupus: effects on antiviral immunity. Nat Rev Nephrol. 2022;18(7):415\u20136.","journal-title":"Nat Rev Nephrol"},{"issue":"1","key":"1154_CR8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaad.2021.12.067","volume":"87","author":"L Skudalski","year":"2022","unstructured":"Skudalski L, Shahriari N, Torre K, Santiago S, Bibb L, Kodomudi V, Grant-Kels JM, Lu J. Emerging therapeutics in the management of connective tissue disease. Part I. Lupus erythematosus and Sj\u00f6gren syndrome. J Am Acad Dermatol. 2022;87(1):1\u201318.","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"1154_CR9","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1136\/annrheumdis-2019-216379","volume":"79","author":"FA Houssiau","year":"2020","unstructured":"Houssiau FA, Thanou A, Mazur M, Ramiterre E, Gomez MD, Misterska-Skora M, Perich-Campos RA, Smakotina SA, Cerpa CS, Louzir B, Croughs T, Tee ML. IFN-\u03b1 kinoid in systemic lupus erythematosus: results from a phase IIb, randomised, placebo-controlled study. Ann Rheum Dis. 2020;79(3):347\u201355.","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"1154_CR10","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu G, Wang LG, Han Y, He QY. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16(5):284\u20137.","journal-title":"OMICS"},{"key":"1154_CR11","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S H\u00e4nzelmann","year":"2013","unstructured":"H\u00e4nzelmann S, Castelo R, Guinney J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinform. 2013;14:7.","journal-title":"BMC Bioinform"},{"issue":"12","key":"1154_CR12","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1093\/bioinformatics\/btq170","volume":"26","author":"MD Wilkerson","year":"2010","unstructured":"Wilkerson MD, Hayes DN. ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking. Bioinformatics. 2010;26(12):1572\u20133.","journal-title":"Bioinformatics"},{"key":"1154_CR13","doi-asserted-by":"crossref","first-page":"732933","DOI":"10.3389\/fimmu.2021.732933","volume":"12","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Yang W, Li W, Zhao Y. NLRP3 inflammasome: checkpoint connecting innate and adaptive immunity in autoimmune diseases. Front Immunol. 2021;12:732933.","journal-title":"Front Immunol"},{"issue":"10188","key":"1154_CR14","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1016\/S0140-6736(19)30546-X","volume":"393","author":"T D\u00f6rner","year":"2019","unstructured":"D\u00f6rner T, Furie R. Novel paradigms in systemic lupus erythematosus. Lancet. 2019;393(10188):2344\u201358.","journal-title":"Lancet"},{"key":"1154_CR15","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1146\/annurev-pathol-020117-043952","volume":"14","author":"MK Crow","year":"2019","unstructured":"Crow MK, Olferiev M, Kirou KA. Type I interferons in autoimmune disease. Annu Rev Pathol. 2019;14:369\u201393.","journal-title":"Annu Rev Pathol"},{"issue":"2","key":"1154_CR16","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1007\/s10067-004-1024-2","volume":"24","author":"TB Niewold","year":"2005","unstructured":"Niewold TB, Swedler WI. Systemic lupus erythematosus arising during interferon-alpha therapy for cryoglobulinemic vasculitis associated with hepatitis C. Clin Rheumatol. 2005;24(2):178\u201381.","journal-title":"Clin Rheumatol"},{"issue":"11","key":"1154_CR17","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1136\/annrheumdis-2015-208140","volume":"75","author":"ME Munroe","year":"2016","unstructured":"Munroe ME, Lu R, Zhao YD, Fife DA, Robertson JM, Guthridge JM, Niewold TB, Tsokos GC, Keith MP, Harley JB, James JA. Altered type II interferon precedes autoantibody accrual and elevated type I interferon activity prior to systemic lupus erythematosus classification. Ann Rheum Dis. 2016;75(11):2014\u201321.","journal-title":"Ann Rheum Dis"},{"key":"1154_CR18","doi-asserted-by":"crossref","first-page":"996662","DOI":"10.3389\/fimmu.2022.996662","volume":"13","author":"Z Liu","year":"2022","unstructured":"Liu Z, Cheng R, Liu Y. Evaluation of anifrolumab safety in systemic lupus erythematosus: a meta-analysis and systematic review. Front Immunol. 2022;13:996662.","journal-title":"Front Immunol"},{"key":"1154_CR19","first-page":"4053038","volume":"2022","author":"S Luo","year":"2022","unstructured":"Luo S, Wu R, Li Q, Zhang G. Epigenetic regulation of IFI44L expression in monocytes affects the functions of monocyte-derived dendritic cells in systemic lupus erythematosus. J Immunol Res. 2022;2022:4053038.","journal-title":"J Immunol Res"},{"key":"1154_CR20","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.trsl.2021.07.006","volume":"238","author":"KZ Siddiqi","year":"2021","unstructured":"Siddiqi KZ, Wilhelm TR, Ulff-M\u00f8ller CJ, Jacobsen S. Cluster of highly expressed interferon-stimulated genes associate more with African ancestry than disease activity in patients with systemic lupus erythematosus: a systematic review of cross-sectional studies. Transl Res. 2021;238:63\u201375.","journal-title":"Transl Res"},{"key":"1154_CR21","first-page":"8","volume":"2017","author":"T Sezin","year":"1992","unstructured":"Sezin T, Vorobyev A, Sadik CD, Zillikens D, Gupta Y, Ludwig RJ. Gene expression analysis reveals novel shared gene signatures and candidate molecular mechanisms between pemphigus and systemic lupus erythematosus in CD4(+) T cells. Front Immunol. 1992;2017:8.","journal-title":"Front Immunol"},{"issue":"12","key":"1154_CR22","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1002\/art.40576","volume":"70","author":"J Wang","year":"2018","unstructured":"Wang J, Dai M, Cui Y, Hou G, Deng J, Gao X, Liao Z, Liu Y, Meng Y, Wu L, Yao C, Wang Y, Qian J, Guo Q, Ding H, Qu B, Shen N. Association of abnormal elevations in IFIT3 with overactive cyclic GMP-AMP synthase\/stimulator of interferon genes signaling in human systemic lupus erythematosus monocytes. Arthritis Rheumatol. 2018;70(12):2036\u201345.","journal-title":"Arthritis Rheumatol"},{"key":"1154_CR23","doi-asserted-by":"crossref","unstructured":"Martin-Fernandez M, Buta S, Le Voyer T, Li Z, Dynesen LT, Vuillier F, Franklin L, Ailal F, Muglia AA, Malle L, Gruber C, Benhsaien I, Altman J, Taft J, Deswarte C, Roynard M, Nieto-Patlan A, Moriya K, Rosain J, Boddaert N, Bousfiha A, Crow YJ, Jankovic D, Sher A, Casanova JL, Pellegrini S, Bustamante J, Bogunovic D. A partial form of inherited human USP18 deficiency underlies infection and inflammation. J Exp Med. 2022;219(4).","DOI":"10.1084\/jem.20211273"},{"issue":"8","key":"1154_CR24","doi-asserted-by":"crossref","first-page":"3491","DOI":"10.1093\/rheumatology\/keac016","volume":"61","author":"E Huijser","year":"2022","unstructured":"Huijser E, Bodewes I, Lourens MS, van Helden-Meeuwsen CG, van den Bosch T, Grashof D, van de Werken H, Lopes AP, van Roon J, van Daele P, Brkic Z, Dik WA, Versnel MA. Hyperresponsive cytosolic DNA-sensing pathway in monocytes from primary Sj\u00f6gren\u2019s syndrome. Rheumatology (Oxford). 2022;61(8):3491\u20136.","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"1154_CR25","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13075-017-1501-z","volume":"20","author":"MJ Wahadat","year":"2018","unstructured":"Wahadat MJ, Bodewes I, Maria NI, van Helden-Meeuwsen CG, van Dijk-Hummelman A, Steenwijk EC, Kamphuis S, Versnel MA. Type I IFN signature in childhood-onset systemic lupus erythematosus: a conspiracy of DNA- and RNA-sensing receptors? Arthritis Res Ther. 2018;20(1):4.","journal-title":"Arthritis Res Ther"},{"issue":"11","key":"1154_CR26","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1038\/s41401-020-00603-2","volume":"42","author":"L Chen","year":"2021","unstructured":"Chen L, Cao SQ, Lin ZM, He SJ, Zuo JP. NOD-like receptors in autoimmune diseases. Acta Pharmacol Sin. 2021;42(11):1742\u201356.","journal-title":"Acta Pharmacol Sin"},{"issue":"1","key":"1154_CR27","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jaci.2016.05.010","volume":"138","author":"LI Labzin","year":"2016","unstructured":"Labzin LI, Lauterbach MA, Latz E. Interferons and inflammasomes: cooperation and counterregulation in disease. J Allergy Clin Immunol. 2016;138(1):37\u201346.","journal-title":"J Allergy Clin Immunol"},{"issue":"9","key":"1154_CR28","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1002\/art.40166","volume":"69","author":"J Liu","year":"2017","unstructured":"Liu J, Berthier CC, Kahlenberg JM. Enhanced inflammasome activity in systemic lupus erythematosus is mediated via type i interferon-induced up-regulation of interferon regulatory factor 1. Arthritis Rheumatol. 2017;69(9):1840\u20139.","journal-title":"Arthritis Rheumatol"},{"issue":"7","key":"1154_CR29","first-page":"E710","volume":"112","author":"S Sharma","year":"2015","unstructured":"Sharma S, Campbell AM, Chan J, Schattgen SA, Orlowski GM, Nayar R, Huyler AH, N\u00fcndel K, Mohan C, Berg LJ, Shlomchik MJ, Marshak-Rothstein A, Fitzgerald KA. Suppression of systemic autoimmunity by the innate immune adaptor STING. Proc Natl Acad Sci USA. 2015;112(7):E710\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1154_CR30","doi-asserted-by":"crossref","first-page":"772","DOI":"10.3389\/fimmu.2019.00772","volume":"10","author":"AA Herrada","year":"2019","unstructured":"Herrada AA, Escobedo N, Iruretagoyena M, Valenzuela RA, Burgos PI, Cuitino L, Llanos C. Innate immune cells\u2019 contribution to systemic lupus erythematosus. Front Immunol. 2019;10:772.","journal-title":"Front Immunol"},{"issue":"1","key":"1154_CR31","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/s41423-019-0343-9","volume":"18","author":"B Deng","year":"2021","unstructured":"Deng B, Lin Y, Chen Y, Ma S, Cai Q, Wang W, Li B, Liu T, Zhou P, He R, Ding F. Plasmacytoid dendritic cells promote acute kidney injury by producing interferon-\u03b1. Cell Mol Immunol. 2021;18(1):219\u201329.","journal-title":"Cell Mol Immunol"},{"issue":"7","key":"1154_CR32","doi-asserted-by":"crossref","first-page":"v9019","DOI":"10.1126\/sciadv.aav9019","volume":"5","author":"N Smith","year":"2019","unstructured":"Smith N, Rodero MP, Bekaddour N, Bondet V, Ruiz-Blanco YB, Harms M, Mayer B, Bader-Meunier B, Quartier P, Bodemer C, Baudouin V, Dieudonn\u00e9 Y, Kirchhoff F, Sanchez GE, Charbit B, Leboulanger N, Jahrsd\u00f6rfer B, Richard Y, Korganow AS, M\u00fcnch J, Nisole S, Duffy D, Herbeuval JP. Control of TLR7-mediated type I IFN signaling in pDCs through CXCR4 engagement-A new target for lupus treatment. Sci Adv. 2019;5(7):v9019.","journal-title":"Sci Adv"},{"key":"1154_CR33","doi-asserted-by":"crossref","first-page":"156015","DOI":"10.1016\/j.cyto.2022.156015","volume":"158","author":"L Shakerian","year":"2022","unstructured":"Shakerian L, Kolahdooz H, Garousi M, Keyvani V, Kamal KR, Abdulsattar FT, Yazdanpanah E, Esmaeili SA. IL-33\/ST2 axis in autoimmune disease. Cytokine. 2022;158:156015.","journal-title":"Cytokine"},{"issue":"2","key":"1154_CR34","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/iid3.567","volume":"10","author":"Y Wang","year":"2022","unstructured":"Wang Y, Wang T, Cai M, Zhu S, Song L, Wang Q. Expression and existence forms of mast cell activating molecules and their antibodies in systemic lupus erythematosus. Immun Inflamm Dis. 2022;10(2):235\u201340.","journal-title":"Immun Inflamm Dis"},{"key":"1154_CR35","doi-asserted-by":"crossref","first-page":"952304","DOI":"10.3389\/fmed.2022.952304","volume":"9","author":"I Parodis","year":"2022","unstructured":"Parodis I, Gatto M, Sj\u00f6wall C. B cells in systemic lupus erythematosus: targets of new therapies and surveillance tools. Front Med (Lausanne). 2022;9:952304.","journal-title":"Front Med (Lausanne)"},{"issue":"2","key":"1154_CR36","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/s41584-020-00544-4","volume":"17","author":"S Fillatreau","year":"2021","unstructured":"Fillatreau S, Manfroi B, D\u00f6rner T. Toll-like receptor signalling in B cells during systemic lupus erythematosus. Nat Rev Rheumatol. 2021;17(2):98\u2013108.","journal-title":"Nat Rev Rheumatol"},{"key":"1154_CR37","doi-asserted-by":"crossref","unstructured":"Ort\u00edz-Fern\u00e1ndez L, Mart\u00edn J, Alarc\u00f3n-Riquelme ME. A summary on the genetics of systemic lupus erythematosus, rheumatoid arthritis, systemic sclerosis, and Sj\u00f6gren's syndrome. Clin Rev Allergy Immunol. 2022.","DOI":"10.1007\/s12016-022-08951-z"},{"key":"1154_CR38","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.clim.2016.09.012","volume":"185","author":"T Iwamoto","year":"2017","unstructured":"Iwamoto T, Niewold TB. Genetics of human lupus nephritis. Clin Immunol. 2017;185:32\u20139.","journal-title":"Clin Immunol"},{"issue":"5","key":"1154_CR39","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.semnephrol.2015.08.002","volume":"35","author":"ME Munroe","year":"2015","unstructured":"Munroe ME, James JA. Genetics of lupus nephritis: clinical implications. Semin Nephrol. 2015;35(5):396\u2013409.","journal-title":"Semin Nephrol"},{"issue":"1","key":"1154_CR40","doi-asserted-by":"crossref","first-page":"7442","DOI":"10.1038\/s41598-019-43173-y","volume":"9","author":"WY Teo","year":"2019","unstructured":"Teo WY, Sekar K, Seshachalam P, Shen J, Chow WY, Lau CC, Yang H, Park J, Kang SG, Li X, Nam DH, Hui KM. Relevance of a TCGA-derived glioblastoma subtype gene-classifier among patient populations. Sci Rep. 2019;9(1):7442.","journal-title":"Sci Rep"},{"key":"1154_CR41","unstructured":"Marketos N, Cinoku I, Rapti A, Mavragani CP. Type I interferon signature in Sj\u00f6gren's syndrome: pathophysiological and clinical implications. Clin Exp Rheumatol. 2019;37 Suppl 118(3): 185\u201391."},{"issue":"2","key":"1154_CR42","doi-asserted-by":"crossref","first-page":"166302","DOI":"10.1016\/j.bbadis.2021.166302","volume":"1868","author":"J Zhou","year":"2022","unstructured":"Zhou J, Zhang X, Yu Q. Plasmacytoid dendritic cells promote the pathogenesis of Sj\u00f6gren\u2019s syndrome. Biochim Biophys Acta Mol Basis Dis. 2022;1868(2):166302.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"5","key":"1154_CR43","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1093\/rheumatology\/kex490","volume":"57","author":"I Bodewes","year":"2018","unstructured":"Bodewes I, Al-Ali S, van Helden-Meeuwsen CG, Maria NI, Tarn J, Lendrem DW, Schreurs M, Steenwijk EC, van Daele P, Both T, Bowman SJ, Griffiths B, Ng WF, Versnel MA. Systemic interferon type I and type II signatures in primary Sj\u00f6gren\u2019s syndrome reveal differences in biological disease activity. Rheumatology (Oxford). 2018;57(5):921\u201330.","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"1154_CR44","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.4110\/in.2020.20.e39","volume":"20","author":"SM Hong","year":"2020","unstructured":"Hong SM, Lee J, Jang SG, Lee J, Cho ML, Kwok SK, Park SH. Type I interferon increases inflammasomes associated pyroptosis in the salivary glands of patients with primary Sj\u00f6gren\u2019s syndrome. Immune Netw. 2020;20(5):e39.","journal-title":"Immune Netw"},{"issue":"5","key":"1154_CR45","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/BOR.0000000000000524","volume":"30","author":"GE Thorlacius","year":"2018","unstructured":"Thorlacius GE, Wahren-Herlenius M, R\u00f6nnblom L. An update on the role of type I interferons in systemic lupus erythematosus and Sj\u00f6gren\u2019s syndrome. Curr Opin Rheumatol. 2018;30(5):471\u201381.","journal-title":"Curr Opin Rheumatol"},{"key":"1154_CR46","doi-asserted-by":"crossref","first-page":"7682827","DOI":"10.1155\/2019\/7682827","volume":"2019","author":"S Colafrancesco","year":"2019","unstructured":"Colafrancesco S, Ciccacci C, Priori R, Latini A, Picarelli G, Arienzo F, Novelli G, Valesini G, Perricone C, Borgiani P. STAT4, TRAF3IP2, IL10, and HCP5 polymorphisms in Sj\u00f6gren\u2019s syndrome: association with disease susceptibility and clinical aspects. J Immunol Res. 2019;2019:7682827.","journal-title":"J Immunol Res"},{"issue":"7","key":"1154_CR47","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1136\/annrheumdis-2017-212794","volume":"77","author":"N Hagberg","year":"2018","unstructured":"Hagberg N, Joelsson M, Leonard D, Reid S, Eloranta ML, Mo J, Nilsson MK, Syv\u00e4nen AC, Bryceson YT, R\u00f6nnblom L. The STAT4 SLE risk allele rs7574865[T] is associated with increased IL-12-induced IFN-\u03b3 production in T cells from patients with SLE. Ann Rheum Dis. 2018;77(7):1070\u20137.","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"1154_CR48","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1136\/annrheumdis-2015-208659","volume":"75","author":"J Imgenberg-Kreuz","year":"2016","unstructured":"Imgenberg-Kreuz J, Sandling JK, Alml\u00f6f JC, Nordlund J, Sign\u00e9r L, Norheim KB, Omdal R, R\u00f6nnblom L, Eloranta ML, Syv\u00e4nen AC, Nordmark G. Genome-wide DNA methylation analysis in multiple tissues in primary Sj\u00f6gren\u2019s syndrome reveals regulatory effects at interferon-induced genes. Ann Rheum Dis. 2016;75(11):2029\u201336.","journal-title":"Ann Rheum Dis"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-023-01154-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-023-01154-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-023-01154-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,16]],"date-time":"2023-12-16T16:16:12Z","timestamp":1702743372000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10238-023-01154-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,5]]},"references-count":48,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1154"],"URL":"https:\/\/doi.org\/10.1007\/s10238-023-01154-6","relation":{},"ISSN":["1591-9528"],"issn-type":[{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,5]]},"assertion":[{"value":"2 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Contributorship"}},{"value":"The authors declare no conflict of interest and the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}